Helbig, G., G. Bober, M. Seweryn, R. Wichary, A. Tukiendorf, L. Sedlak, T. Oleksy, and S. Kyrcz-Krzemien. “OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 7, no. 1, Jan. 2015, p. e2015003, doi:10.4084/mjhid.2015.003.